Literature DB >> 16754794

Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults.

Itamar Grotto1, Ehud Grossman, Michael Huerta, Yehonatan Sharabi.   

Abstract

Recently the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure introduced the term "prehypertension" for systolic blood pressure levels of 120 to 139 mm Hg and diastolic BP levels of 80 to 89 mm Hg. Little is known about the prevalence of this entity and the cardiovascular risk factors associated with it. We aimed to determine the prevalence of prehypertension and the cardiovascular risk factors associated with it in a large population-based sample of young Israeli adults. We studied 36,424 Israel Defense Forces employees during the years 1991 to 1999. Subjects completed a detailed questionnaire and underwent physical examination, and blood samples were drawn after a 14-hour fast. Prehypertension was defined as a systolic blood pressure of 120 to 139 mm Hg, and/or a diastolic blood pressure of 80 to 89 mm Hg. We calculated the age- and sex-specific prevalence of prehypertension and other cardiovascular risk factors associated with this condition. Prehypertension was observed among 50.6% of men and 35.9% of women. The prehypertensive group had higher levels of blood glucose, total cholesterol, low-density lipoprotein cholesterol, and triglycerides, higher body mass index, and lower levels of high-density lipoprotein cholesterol than did the normotensive group. Multivariate logistic regression analysis showed that body mass index was the strongest predictor of prehypertension among both males and females (odds ratio, 1.100; 95% CI, 1.078 to 1.122 and odds ratio, 1.152; 95% CI, 1.097 to 1.21, respectively, for every 1 kg/m2 increase). Our findings support the recommendation of lifestyle modification for prehypertensive patients. Further prospective studies are required to determine the role of pharmacotherapy in prehypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16754794     DOI: 10.1161/01.HYP.0000227507.69230.fc

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  33 in total

1.  [Prevalence of obesity related pre-hypertension and hypertension].

Authors:  Miguel Angel Robles Romero; Jaime Eduardo Guzmán Pantoja; Beatriz Adriana Herrera Guadalupe; Francisco Javier Valadez Toscano
Journal:  Aten Primaria       Date:  2009-05-08       Impact factor: 1.137

2.  The Prevalence of Elevated Blood Pressure in Adolescents in Nassau, The Bahamas.

Authors:  C Conliffe; M Frankson; F Smith; C Hanna-Mahase; M Oriakhi
Journal:  West Indian Med J       Date:  2015-04-28       Impact factor: 0.171

3.  Prevalence of prehypertension and associated risk factors among health check-up population in Guangzhou, China.

Authors:  Rui Wang; Xia Lu; Yan Hu; Tianhui You
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Association of Out-of-Pocket Annual Health Expenditures With Financial Hardship in Low-Income Adults With Atherosclerotic Cardiovascular Disease in the United States.

Authors:  Rohan Khera; Javier Valero-Elizondo; Victor Okunrintemi; Anshul Saxena; Sandeep R Das; James A de Lemos; Harlan M Krumholz; Khurram Nasir
Journal:  JAMA Cardiol       Date:  2018-08-01       Impact factor: 14.676

5.  Prevalence and Determinants of Pre-Hypertension among Omani Adults Attending Non-Communicable Disease Screening Program in Primary Care Setting in Sohar City.

Authors:  Ali Abdullah Al-Maqbali; Meredith Temple-Smith; John Ferler; Irene Blackberry
Journal:  Oman Med J       Date:  2013-09

Review 6.  Should we treat prehypertension in diabetes? What are the cons?

Authors:  Ehud Grossman
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

7.  Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease.

Authors:  Suzi Hong; Stoyan Dimitrov; Tiefu Cheng; Laura Redwine; Christopher Pruitt; Paul J Mills; Michael G Ziegler; J Michael Green; Farah Shaikh; Kathleen Wilson
Journal:  Brain Behav Immun       Date:  2015-08-20       Impact factor: 7.217

Review 8.  Prehypertension: epidemiology, consequences and treatment.

Authors:  Eduardo Pimenta; Suzanne Oparil
Journal:  Nat Rev Nephrol       Date:  2009-11-17       Impact factor: 28.314

9.  Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study.

Authors:  Marina De Marco; Giovanni de Simone; Mary J Roman; Marcello Chinali; Elisa T Lee; Marie Russell; Barbara V Howard; Richard B Devereux
Journal:  Hypertension       Date:  2009-08-31       Impact factor: 10.190

Review 10.  How to define prehypertension in diabetes/metabolic syndrome.

Authors:  Avshalom Leibowitz; Ehud Grossman
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.